| Name |
Date |
Price (USD) |
Description |
|
Allergan Inc: PharmaVitae Profile |
12-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Allergan in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Biogen Idec Inc: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Biogen Idec
in the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Chugai: PharmaVitae Profile |
18-Oct-07 |
5700 |
This analysis examines the historical and forecast performance for Chugai in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Daiichi Sankyo Co Ltd: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Daiichi Sankyo
in the ethical pharma sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Eisai Co Ltd: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Eisai in the
ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Forest Laboratories Inc: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Forest in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Genzyme Corporation: PharmaVitae Profile |
12-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Genzyme in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Gilead Sciences Inc: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Gilead in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Gilead: PharmaVitae Profile
|
18-Jan-07 |
5700 |
This analysis examines the historical and forecast performance for Gilead in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Menarini: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Menarini in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Menarini: PharmaVitae Profile |
22-Mar-07 |
5700 |
This analysis examines the historical and forecast performance for Menarini in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Merck Serono SA: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Merck-Serono
in the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Novo Nordisk A/S: PharmaVitae Profile |
31-Oct-07 |
5700 |
This analysis examines the historical and forecast performance for Novo Nordisk
in the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Organon: PharmaVitae Profile |
31-Oct-07 |
5700 |
This analysis examines the historical and forecast performance for Organon in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Servier: PharmaVitae Profile |
26-Feb-07 |
5700 |
This analysis examines the historical and forecast performance for Servier in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Solvay SA: PharmaVitae Profile |
25-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Solvayin the
ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Solvay SA: PharmaVitae Profile |
21-Mar-07 |
5700 |
This analysis examines the historical and forecast performance for Solvay in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
UCB SA: PharmaVitae Profile |
14-Nov-07 |
5700 |
This analysis examines the historical and forecast performance for UCB in the
ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
